Tata sells Advinus Therapeutics to Eurofins Scientific

Published On 2017-07-22 04:17 GMT   |   Update On 2017-07-22 04:17 GMT

The Tata Group and the individual shareholders of Advinus Therapeutics decided to sell the company to Eurofins Scientific for an undisclosed sum.


Advinus is owned by Tata Sons, Tata Industries and Rallis India and a few individual shareholders, the Tata Group said in a statement adding that they expect the transaction to close in the next several weeks.


Advinus is a leading preclinical contract research company for safety assessment, CMC services, DMPK and analytical R&D services, while Eurofins is into contract research and development.


The Bengaluru-based Advinus serves diverse industries like biotech, pharma, biologics, agrochemicals, nutraceuticals and cosmetics.


Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News